SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-012539
Filing Date
2023-05-04
Accepted
2023-05-04 15:42:45
Documents
16
Period of Report
2023-05-02
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20230504_8k.htm   iXBRL 8-K 26715
2 EXHIBIT 4.1 ex_513742.htm EX-4.1 54254
3 EXHIBIT 10.1 ex_513743.htm EX-10.1 112456
4 EXHIBIT 10.2 ex_513744.htm EX-10.2 157008
  Complete submission text file 0001437749-23-012539.txt   568521

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230502.xsd EX-101.SCH 4036
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230502_def.xml EX-101.DEF 13508
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230502_lab.xml EX-101.LAB 17665
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230502_pre.xml EX-101.PRE 13475
10 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230504_8k_htm.xml XML 4286
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 23888333
SIC: 2836 Biological Products, (No Diagnostic Substances)